Literature DB >> 16887035

Giant pulmonary hamartoma.

Somshekar Ganti1, Richard Milton, Les Davidson, Vladimir Anikin.   

Abstract

Pulmonary hamartomas are usually an incidental finding and range in size from 1 cm to 8 cm in diameter in various series. We report a case of a massive pulmonary hamartoma (size 25.5 x 17.5 x 6.5 cm and weighing 1134 g) in a 61 year old male who presented with a short history of breathlessness. The tumour was arising from the medial border of the right lung and occupying most of the right chest extending in to the anterior mediastinum. The tumour was compressing the right lung and there was no evidence of infiltration into the surrounding structures. It was successfully treated by surgical resection and final histology was pulmonary hamartoma with predominantly adipose and leiomyomatous differentiation.

Entities:  

Mesh:

Year:  2006        PMID: 16887035      PMCID: PMC1552053          DOI: 10.1186/1749-8090-1-19

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


Introduction

Pulmonary hamartomas, also known as mesenchymomas, can be parenchymal (80%) or endobronchial (10–20%) in location [1]. Parenchymal lesions are usually an incidental finding and range in size from 1 cm to 8 cm in diameter in various series [6]. The endobronchial tumours usually present with new onset respiratory symptoms most commonly recurrent chest infections or haemoptysis [1]. We report a case of giant hamartoma which we believe is the largest reported case in literature yet, and this was successfully resected via a median sternotomy.

Case report

A previously healthy 61-year-old man was investigated for worsening breathlessness. Chest radiography demonstrated a mass in the right chest and a subsequent CT scan revealed a large anterior mediastinal mass extending mostly into the right hemithorax and compressing the right lung. The radiological appearances were consistent with a teratoma (Fig. 1A–B). The CT scan also revealed abdominal lymphadenopathy, which on biopsy proved to be non-Hodgkin's lymphoma. The lymphoma was successfully treated with chemotherapy, without any change in the lung mass. Nevertheless, surgical excision of this mass was indicated due to its large size.
Figure 1

Chest radiograph showing soft tissue mass within the right hemithorax (A). CT (B) demonstrates that the mass contains low attenuation soft tissue suggestive of fat, and calcification, features in keeping with a teratoma.

Chest radiograph showing soft tissue mass within the right hemithorax (A). CT (B) demonstrates that the mass contains low attenuation soft tissue suggestive of fat, and calcification, features in keeping with a teratoma. The patient underwent a median sternotomy whereupon a giant fatty tumour was found arising superficially from the medial border of the right lung occupying most of the right chest and extending to the anterior mediastinum. The mass was compressing the right lung with no evidence of local invasion. The right phrenic nerve was identified and preserved, and the tumour was found to be adherent to the medial border of the lung and was easily dissected with sharp dissection and removed en bloc. The postoperative recovery was uneventful and the patient was discharged home on the seventh postoperative day. Six months postoperatively the patient remains well. The final histology of the tumour, measuring 25.5 × 17.5 × 6.5 cm, and weighing 1134 g (Fig. 2), was a pulmonary hamartoma with predominantly adipose and leiomyomatous differentiation.
Figure 2

Photograph of the resected hamartoma.

Photograph of the resected hamartoma.

Discussion

Pulmonary hamartomas or mesenchymomas are the most common form of benign lung tumours with an incidence of between 0.025% – 0.32% according to different necropsy studies [1]. In a large series they constituted 7–14% of all coin lesions [2]. Most of these are parenchymal lesions with endobronchial lesions making up only about 10% [1]. The peak incidence is between the sixth and seventh decades with a male preponderance [3]. The parenchymal lesions are usually an incidental radiological finding of a round homogeneous opacity in the periphery, whereas endobronchial lesions are usually associated with haemoptysis and obstructive pneumonia [4]. The size of these parenchymal lesions ranges from 1–8 cm and the tumour in our case is more than 3 times that of any previously published [6,7]. The histology of the parenchymal lesions usually reveals a predominant chondroid differentiation (80%), with fibroblastic (12%), fatty (5%) and osseous (3%) differentiation making the rest [3,7]. In our case it was predominantly made of adipose and leiomyomatous differentiation. The size of the tumour and the histology make it an unusual presentation.
  6 in total

Review 1.  Pulmonary hamartoma. A clinical study of 77 cases in a 21-year period and review of literature.

Authors:  U S Salminen
Journal:  Eur J Cardiothorac Surg       Date:  1990       Impact factor: 4.191

Review 2.  Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases.

Authors:  J M van den Bosch; S S Wagenaar; B Corrin; J R Elbers; P J Knaepen; C J Westermann
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

3.  The coin lesion story: update 1976. Twenty years' experience with thoracotomy for 179 suspected malignant coin lesions.

Authors:  J F Ray; B R Lawton; G E Magnin; W V Dovenbarger; W A Smullen; C N Reyes; W O Myers; F J Wenzel; R D Sautter
Journal:  Chest       Date:  1976-09       Impact factor: 9.410

4.  Pulmonary hamartoma and malignancy.

Authors:  M Ribet; S Jaillard-Thery; M C Nuttens
Journal:  J Thorac Cardiovasc Surg       Date:  1994-02       Impact factor: 5.209

5.  Endobronchial hamartoma.

Authors:  Borja G Cosío; Victoria Villena; Jose Echave-Sustaeta; Eduardo de Miguel; Jose Alfaro; Luis Hernandez; Teresa Sotelo
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

6.  Pulmonary hamartomas.

Authors:  J A Gjevre; J L Myers; U B Prakash
Journal:  Mayo Clin Proc       Date:  1996-01       Impact factor: 7.616

  6 in total
  9 in total

1.  A 31-year-old woman with hemoptysis and an intrathoracic mass.

Authors:  Madison Macht; John D Mitchell; Carlyne Cool; David A Lynch; Ashok Babu; Marvin I Schwarz
Journal:  Chest       Date:  2010-07       Impact factor: 9.410

2.  Successful removal of a giant pulmonary hamartoma coexisting with an anomalous common pulmonary venous trunk.

Authors:  Hui Shi; Zhong-Xi Niu; Jun Peng; Yu-Shang Yang; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Pulmonary Hamartoma Mimicking Malignancy: A Cytopathological Diagnosis.

Authors:  Manjari Kishore; Prajwala Gupta; Desh Deepak
Journal:  J Clin Diagn Res       Date:  2016-11-01

4.  Incidental pathologically proven pulmonary hamartoma in a patient with carcinoma tongue.

Authors:  Aditya Jindal; Karan Madan; Raje Nijhawan; Navneet Singh
Journal:  BMJ Case Rep       Date:  2013-03-25

5.  Pulmonary hamartoma treated by thoracoscopic enucleation.

Authors:  Suguru Yamashita; Mingyon Mun; Tadasu Kono
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-01-09

6.  Successful use of snare electrocautery via flexible fiberoptic bronchoscopy for removal of an endobronchial hamartoma causing chronic lung atelectasis and mimicking malignancy.

Authors:  Chao Liu; Jia-Jia Wang; Ye-Han Zhu; Cheng Chen
Journal:  Ther Adv Respir Dis       Date:  2017-12       Impact factor: 4.031

7.  Giant hamartoma of lung presented with massive hemoptysis: A rare case report and review of the literature.

Authors:  Bita Geramizadeh; Maedeh Mottavvas; Bijan Zeyaian; Armin Amirian
Journal:  Rare Tumors       Date:  2019-01-10

8.  A pulmonary hamartoma in Covid-19 pneumonia: an interesting case studied with computed tomography.

Authors:  Francesco Messina; Grazia Calabrese; Lorena Turano; Carmela Tebala; Nicola Arcadi
Journal:  Radiol Case Rep       Date:  2021-01-31

9.  Trends, Symptoms, and Outcomes of Resectable Giant Mediastinal Tumors.

Authors:  Xiaoshun Shi; Xiguang Liu; Xiaoying Dong; Hua Wu; Kaican Cai
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.